Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Renal function: an emerging risk factor for cardiovascular disease?

M J Landray, C Baigent

    Evidence-Based Cardiovascular Medicine
    |December 29, 2005
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease.

    European heart journal·2021
    Same author

    Effect on non-vascular outcomes of lowering LDL cholesterol in patients with chronic kidney disease: results from the Study of Heart and Renal Protection.

    BMC nephrology·2017
    Same author

    Randomized Evaluation of the Effects of Anacetrapib through Lipid-modification (REVEAL)-A large-scale, randomized, placebo-controlled trial of the clinical effects of anacetrapib among people with established vascular disease: Trial design, recruitment, and baseline characteristics.

    American heart journal·2017
    Same author

    Coxibs, Traditional NSAIDs, and Cardiovascular Safety Post-PRECISION: What We Thought We Knew Then and What We Think We Know Now.

    Clinical pharmacology and therapeutics·2017
    Same author

    Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials.

    BMJ (Clinical research ed.)·2013
    Same author

    Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials.

    Lancet (London, England)·2013
    Same journal

    Epsilon-aminocaproic acid does not reduce blood transfusions following cardiac surgery.

    Evidence-based cardiovascular medicine·2006
    Same journal

    Clarithromycin may increase cardiovascular mortality in people with stable heart disease.

    Evidence-based cardiovascular medicine·2006
    Same journal

    Miniextracorporeal circulation system appears safe and effective in coronary artery bypass grafting.

    Evidence-based cardiovascular medicine·2006
    Same journal

    Oral amiodarone prophylaxis reduces atrial tachyarrhythmia following cardiac surgery.

    Evidence-based cardiovascular medicine·2006
    Same journal

    Surgical treatment may have better mid-term outcomes than percutaneous therapy in people with isolated LAD disease.

    Evidence-based cardiovascular medicine·2006
    Same journal

    Pravastatin, simvastatin, and atorvastatin appear equally effective for preventing cardiovascular events.

    Evidence-based cardiovascular medicine·2006
    See all related articles